✦ LIBER ✦

Trusted third parties (volume 1, number 1)

Book ID: 104404783
Publisher: Elsevier Science
Year: 1999
Tongue: English
Weight: 88 KB
Volume: 4
Category: Article
ISSN: 1363-4127
DOI: 10.1016/s1363-4127(99)80072-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

✍ Trent Evans 📂 Fiction 📅 2016 🏛 Shadow Moon Press 🌐 English ⚖ 438 KB

A collection of the first three books in the ongoing Dominion Trust steamy romance series. Possessive alpha heroes. Strong, but yielding submissive women. And the deepening mystery of the true purpose of the shadowy Trust... and the uncertainty of its future. Does power always corrupt? Does privil

Highlights: Volume 224, Number 1

📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 161 KB

Mesoangioblasts are vessel-associated multipotent stem cells characterized by the ability to migrate in vivo to inflammation sites. When delivered intra-arterially in distrophic or infarcted mice, they participate in the repair of damaged tissues by producing important factors such as FGF-2 that lac

Highlights: Volume 225, Number 1

📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 203 KB

Highlights: Volume 226, Number 1

📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 116 KB

Features: Volume 110, Number 1

📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB

Features: Volume 112, Number 1

📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 146 KB

Beyond the well recognized effect of KRAS mutations in determining de novo ineffi cacy of cetuximab in metastatic colorectal cancer, there is a need for a biomarker signature for predicting cetuximab effi cacy in KRAS wild-type tumors. In this paper by Oliveras-Ferraros et al, cetuximab-adapted EGFR